Fundz

Syncell raised $15 million in a Series A funding round led by Taiwania Capital to accelerate the global commercialization of its Microscoop platform.

PRIVATEDec 11, 2024

Amount Raised

$15 Million

Round Type

Series A

BiotechnologyHealth Care

Investors

Taiwania Capital

Description

Syncell has successfully closed a $15 million Series A funding round, increasing its total funding to $30 million. This investment will support the expansion and commercial growth of its innovative protein purification and spatial proteomics technology.

Quick answer

Syncell raised $15 Million in a Series A round, dated December 11, 2024. Investors: Taiwania Capital.

How much did Syncell raise?
Syncell raised $15 Million in a Series A round on December 11, 2024.
Who invested in Syncell?
Taiwania Capital is named as investors in this round.
What does Syncell do?
Syncell is a life science tools company revolutionizing proteome and biomarker discovery.
Who are the decision-makers at Syncell?
Fundz holds 1 contact at Syncell. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Syncell that raised within 45 days of this round, from Fundz verified event records.

  • Vessl Prosthetics raised an undisclosed amount (Pre-Seed) on January 24, 2025.
  • Nanopath raised $5.3M on January 24, 2025.
  • Medow Health raised $2M (Seed) on January 24, 2025.
  • Heartflow, Inc. raised $48M on January 24, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • SVASTEK raised $231K (Seed) on January 23, 2025.

Who to call at Syncell, and when

A new round usually means Syncell is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Syncell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syncell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syncell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syncell

About

Syncell is a life science tools company revolutionizing proteome and biomarker discovery. Imagine that you have a subcellular “pickable” microscope to let you isolate and identify proteins at a specific location you like under the microscope. Syncell’s groundbreaking Microscoop platform enables hypothesis-free subcellular spatial proteomics with high sensitivity and specificity. Researchers are able to use Syncell Microscoop to discover proteins novel at specific locations of interest from cell and tissue samples. This pioneering technology revolutionizes how novel molecular mechanisms can be identified and how novel biomarkers can be revealed for diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syncell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Syncell's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Syncell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.